Amphastar Pharmaceuticals Inc (AMPH)
ROA
Obliczenia
|
2023 (31 gru 2023) |
2022 (31 gru 2022) |
2021 (31 gru 2021) |
2020 (31 gru 2020) |
2019 (31 gru 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | 137 545 | 91 386 | 62 116 | 1 403 | 48 939 |
| Aktywa razem | w tys. USD | 1 512 910 | 741 987 | 671 529 | 631 236 | 586 971 |
| ROA | 9,09% | 12,32% | 9,25% | 0,22% | 8,34% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $137 545K ÷ $1 512 910K
= 9,09%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Dynavax Technologies Corp.
DVAX
-0,64%
Harmony Biosciences Holdings Inc
HRMY
15,88%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Ligand Pharmaceuticals, Inc.
LGND
6,63%
Myriad Genetics, Inc.
MYGN
-22,97%
Pacira BioSciences Inc
PCRX
2,66%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%